Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan.
Trials
; 20(1): 164, 2019 Mar 14.
Article
in En
| MEDLINE
| ID: mdl-30871594
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cerebrovascular Circulation
/
Multiple Sclerosis, Relapsing-Remitting
/
Endothelin Receptor Antagonists
/
Bosentan
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2019
Document type:
Article
Affiliation country:
Belgium
Country of publication:
United kingdom